Steroid maker sold other drugs in MN
A Massachusetts company at the center of a deadly meningitis outbreak was selling medications to some of the largest medical groups in Minnesota even though it had no license to do so, the Star Tribune has learned. The New England Compounding Center, which is under investigation for selling tainted steroids, has supplied a host of other drugs to the Mayo Clinic, Allina, HealthPartners and other hospitals and clinics—many more than previously disclosed—officials confirmed in interviews. Questions are surfacing about the company's sales practices as it went around the country marketing hundreds of drugs to hospitals and clinics even though it was not subject to the strict federal safety rules that apply to drug manufacturers.
- Providers Lag as Consumers Set Agenda
- ICD-10 Delay Alters Provider, Vendor Prep
- Crisis Spurs Healthcare Payment Reform in Arkansas
- Esther Dyson Launches Population Health Challenge
- Look Beyond Nurse-Patient Ratios
- Payment Reform Naysayers 'Better Wake Up'
- HIT Leaders Want Flexibility, Transparency from Next HHS Chief
- Reduce Readmissions by Activating Patients to Do 'Self-Care'
- Hospital Groups Back NQF Report on Patient Sociodemographics
- As Hospitalist Patient Loads Rise, So Do Hospital Costs